Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
301 6 |
Ultima descărcare din IBN: 2024-03-16 20:13 |
Căutarea după subiecte similare conform CZU |
616.36-002-07:616.24-002.5 (1) |
Заболевания пищеварительной системы. Болезнь пищеварительного тракта (1732) |
Заболевания дыхательной системы (757) |
SM ISO690:2012 SAJIN, Octavian, SPÎNU, Constantin, ISAC, Maria, IZIUMOV, Nina, CHERNIAVSKA (MIRON), Aliona, BUGA, Alexandru, CIOBANU, Igor. Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova. In: One Health and Risk Management, 2023, nr. 4(1), pp. 59-64. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2023.1.07 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
One Health and Risk Management | ||||||
Numărul 4(1) / 2023 / ISSN 2587-3458 /ISSNe 2587-3466 | ||||||
|
||||||
DOI:https://doi.org/10.38045/ohrm.2023.1.07 | ||||||
CZU: 616.36-002-07:616.24-002.5 | ||||||
Pag. 59-64 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introduction. For the first time, in the Republic of Moldova, there was established the seroprevalence of viral hepatitis B, C and E markers in patients with tuberculosis depending on gender, age and geographical areas. Material and methods. 200 blood samples were collected from patients with tuberculosis and tested by the immuno-fermentative method for presence of viral hepatitis B, C and E markers. Results. Following the investigations, it was established that the seroprevalence of the anti HEV Ig marker in patients with tuberculosis is 12.0±2.3%. The seroprevalence of viral hepatitis B marker HBsAg in patients with tuberculosis was 13.5±2.4%, and that of viral hepatitis C anti HCV – 9.0±2.0%. The study of investigations results for the presence of nominated markers depending on the geographical areas showed a significant statistically difference in the seroprevalence of the anti-HEV IgG marker in TB patients in the Central area of the country compared to the Southern area(p<0.05). Conclusions. Patients with tuberculosis showed a high level of seroprevalence of viral hepatitis marker viz. HBsAg - 13.5±2.4%; anti-HVC - 9.0±2.0% and anti-HVE IgG - 12.0±2.3%. People aged 40-49 and > 60 years were the most affected, including males. |
||||||
Cuvinte-cheie seroprevalence, laboratory investigations, viral hepatitis B, C and E, TB patients, seroprevalenţa, investigații de laborator, hepatitele virale B, C și E, bolnavii cu tuberculoză |
||||||
|
Crossref XML Export
<?xml version='1.0' encoding='utf-8'?> <doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'> <head> <doi_batch_id>ibn-172476</doi_batch_id> <timestamp>1714201490</timestamp> <depositor> <depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name> <email_address>idsi@asm.md</email_address> </depositor> <registrant>Asociația de Biosiguranță și Biosecuritate din Republica Moldova</registrant> </head> <body> <journal> <journal_metadata> <full_title>One Health and Risk Management</full_title> <issn media_type='print'>25873458</issn> </journal_metadata> <journal_issue> <publication_date media_type='print'> <year>2023</year> </publication_date> <issue>4(1)</issue> </journal_issue> <journal_article publication_type='full_text'><titles> <title>Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova</title> </titles> <contributors> <person_name sequence='first' contributor_role='author'> <given_name>Octavian</given_name> <surname>Sajin</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Constantin</given_name> <surname>Spînu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Maria</given_name> <surname>Isac</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Nina</given_name> <surname>Iziumov</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Aliona</given_name> <surname>Cherniavska (Miron)</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Alexandru</given_name> <surname>Buga</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Igor</given_name> <surname>Ciobanu</surname> </person_name> </contributors> <publication_date media_type='print'> <year>2023</year> </publication_date> <pages> <first_page>59</first_page> <last_page>64</last_page> </pages> <doi_data> <doi>10.38045/ohrm.2023.1.07</doi> <resource>http://www.crossref.org/</resource> </doi_data> </journal_article> </journal> </body> </doi_batch>